ID
45610
Beschrijving
Principal Investigator: Bruce M. Psaty, MD, PhD, TOPMed Cardiovascular Health Study Project (TOPMed-CHS). University of Washington, Seattle, WA, USA MeSH: Cardiovascular Diseases,Myocardial Infarction,Stroke,Brain Ischemia,Intracranial Hemorrhage,Venous Thromboembolism,Venous Thrombosis,Pulmonary Embolism https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001368 Participants from the Cardiovascular Health Study (CHS), a large population-based longitudinal cohort study (phs000287), have been included in the TOPMed project. Whole genome sequencing will be performed to contribute to multiple analyses, including cardiovascular disease risk factors, subclinical disease measures, the occurrence of myocardial infarction (MI) and stroke, and analyses of venous thromboembolism (VTE).
Link
Trefwoorden
Versies (1)
- 21-02-23 21-02-23 - Chiara Middel
Houder van rechten
Bruce M. Psaty, MD, PhD, TOPMed Cardiovascular Health Study Project (TOPMed-CHS). University of Washington, Seattle, WA, USA
Geüploaded op
21 februari 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs001368 NHLBI TOPMed: Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Project: Cardiovascular Health Study
This sample attributes data table includes sample IDs, body site where sample was collected, histological type, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, study name, blood draw visit, and sampling groups.
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs and consent group information.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes data table includes sample IDs, body site where sample was collected, histological type, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, study name, blood draw visit, and sampling groups.
Similar models
This sample attributes data table includes sample IDs, body site where sample was collected, histological type, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, study name, blood draw visit, and sampling groups.
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs and consent group information.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes data table includes sample IDs, body site where sample was collected, histological type, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, study name, blood draw visit, and sampling groups.
C1299222 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,2])
C0565990 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
C0243098 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])
C0243098 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
C0005834 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,2])